THE REALITY OF CONTINUOUS PHARMACEUTICAL MANUFACTURING
User experiences and the current status of continuous pharmaceutical processing to be addressed during a three-day event near Newcastle, UK
Taking place on 26–28 March 2019, GEA, Siemens and Perceptive Engineering will host an inaugural 3-day conference to examine the fact and fiction of Continuous Manufacturing (CM) in the pharmaceutical industry.
Hear from experts across the industry including AstraZeneca, Bayer, CMAC, GSK, Janssen, MSD, RCPE, UCB Pharma and University of Sheffield to name a few.
With an expected attendance of 80–120 delegates, this must-attend event will focus on the real-life experiences of existing users of CM technology in the development and manufacture of oral solid dosage (OSD) forms.
Contact Details:
Company name: GEA Group
Website: www.gea.com
E-mail: pharma@gea.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
